News from cantargia ab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

31 Jul, 2020, 07:40 BST New number of shares and votes in Cantargia

The number of shares and votes in Cantargia AB (publ) has changed due to the company's Chairman of the Board, Magnus Persson, exercising his right to ...


23 Jun, 2020, 14:09 BST Cantargia Strengthens Management Team With VP Regulatory Affairs and VP CMC

Cantargia AB today announced that its management team will be strengthened by the recruitment of Susanne Lagerlund as VP Regulatory Affairs and Peter ...


22 Jun, 2020, 14:13 BST Cantargia Presents New Preclinical Data on CAN04 at the 2020 AACR Annual Meeting

Cantargia AB ("Cantargia") today presented new preclinical data giving additional knowledge around the mechanisms and thereby relevance of adding the ...


27 May, 2020, 17:44 BST Annual General Meeting in Cantargia AB (publ)

Cantargia's Annual General Meeting on 27 May 2020 resolved in accordance with the following: That no dividend would be paid. To discharge the board...


27 May, 2020, 07:44 BST Cantargia Publishes Interim Report for First Quarter 2020

Cantargia AB's ("Cantargia") interim report for first quarter 2020 is now available on the company's web page...


15 May, 2020, 07:59 BST Cantargia Presents new Preclinical Data on CAN04 in Combination With Chemotherapy at the 2020 AACR Annual Meeting

Cantargia AB ("Cantargia") today announced that new preclinical data supporting the combination of the clinical stage antibody CAN04, with...


04 May, 2020, 07:45 BST Cantargia IND Application for CAN04 Approved by FDA

Cantargia AB today announced that the IND application regarding the antibody CAN04 has been approved by the US FDA. CAN04, an antibody targeting...


28 Apr, 2020, 16:51 BST Notice of Annual General Meeting in Cantargia AB (publ)

The shareholders of Cantargia AB (publ) are invited to the annual general meeting on Wednesday, 27 May 2020, at 16.00 CET at Ideon Gateway,...


07 Apr, 2020, 15:13 BST Cantargia Submits IND Application for CAN04

Cantargia AB today announced that the application for a US IND regarding the antibody CAN04 has been submitted to the US FDA. CAN04, an antibody...


07 Apr, 2020, 11:19 BST Cantargia Provides Update on Development Projects CAN04 and CAN10

Cantargia AB today provided an update on the progress in its development antibody projects CAN04 and CAN10 in response to the ongoing COVID-19...


31 Mar, 2020, 07:50 BST New Number of Shares and Votes in Cantargia

The number of shares and votes in Cantargia AB (publ) has changed due to the recently completed directed share issue (for further information, see...


20 Mar, 2020, 13:13 GMT Prospectus Relating to the Listing of Shares in Cantargia Published

The prospectus relating to the listing of the shares in the directed issue, which was approved by the extraordinary general meeting of Cantargia on...


16 Mar, 2020, 16:10 GMT Extraordinary General Meeting in Cantargia AB (publ)

On 16 March 2020, the extraordinary general meeting in Cantargia resolved to approve the board's resolution of 19 February 2020 to increase the...


10 Mar, 2020, 07:58 GMT Cantargia Acquires Cellerant IP on IL1RAP

Cantargia AB today announced the acquisition of a patent portfolio from Cellerant Therapeutics Inc covering aspects around the interleukin 1 receptor ...


28 Feb, 2020, 08:01 GMT New Number of Shares and Votes in Cantargia

The number of shares and votes in Cantargia AB (publ) has changed due to the recently completed directed share issue (for further information, see...


27 Feb, 2020, 07:53 GMT Cantargia Publishes Full Year Report for 2019

Cantargia AB's ("Cantargia") full year report for 2019 is now available on the company's web page www.cantargia.com/en/investors/financial-reports....


25 Feb, 2020, 14:45 GMT Cantargia Appoints Dr. Ignacio Garcia-Ribas as Chief Medical Officer

Cantargia AB (publ) (Cantargia) today announced it has appointed Dr. Ignacio Garcia-Ribas as Chief Medical Officer (CMO) of Cantargia from March 1,...


20 Feb, 2020, 10:00 GMT Notice of Extraordinary General Meeting in Cantargia AB (publ)

The shareholders of Cantargia AB (publ) are summoned to an extraordinary general meeting on Monday 16 March 2020 at 16.00 CET at the company's...


19 Feb, 2020, 23:05 GMT Cantargia Has Completed a Directed Share Issue of Approximately SEK 410 Million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS...


19 Feb, 2020, 17:25 GMT Cantargia Announces Intention of a Directed Share Issue

Cantargia AB (publ) ("Cantargia" or the "Company") (Nasdaq Stockholm: CANTA) hereby announces its intention of a placement of shares corresponding to ...


14 Feb, 2020, 11:42 GMT Cantargia Advances Development of CAN04 Through Successful Production Scale Up

Cantargia AB (publ) today announced it has reached an important milestone in the development of its antibody project CAN04, currently in clinical...


05 Dec, 2019, 10:14 GMT Cantargia Selects CAN10 as Development Project in Systemic Sclerosis and Myocarditis

Cantargia AB today announced that its research platform CANxx has progressed with the start of a drug development project, CAN10. The project...


02 Dec, 2019, 10:03 GMT Cantargia Reports Positive Interim Data From Ongoing Phase IIa Combination Study With Antibody CAN04

Cantargia AB today announced the first interim data with antibody CAN04 in combination with chemotherapy in the ongoing phase IIa CANFOUR study. The...


25 Nov, 2019, 14:14 GMT Cantargia AB: Nomination Committee Appointed Ahead of 2020 Annual General Meeting

Cantargia AB (publ) hereby provides notification that the Nomination Committee has been appointed ahead of the 2020 Annual General Meeting, and...


18 Nov, 2019, 07:53 GMT Cantargia Presents Novel Preclinical Data on Antibody CAN04 at PEGS Europe Conference

Cantargia AB today announce that new preclinical data on the antibody CAN04 is presented at the 11th annual PEGS (Protein & Antibody Engineering...